Mintu P Turakhia1, Steven Zweibel2, Andrea L Swain2, Sarah A Mollenkopf2, Matthew R Reynolds2. 1. From the Center for Digital Health, Stanford University School of Medicine, Stanford, CA (M.P.T.); the Division of Cardiac Electrophysiology, Hartford Healthcare Heart and Vascular Institute, Hartford, CT (S.Z.); the Department of Economics, Reimbursement, and Evidence, Medtronic plc, Mounds View, MN (A.L.S., S.A.M.); and Baim Institute for Clinical Research, Boston, MA (M.R.R.). mintu@stanford.edu. 2. From the Center for Digital Health, Stanford University School of Medicine, Stanford, CA (M.P.T.); the Division of Cardiac Electrophysiology, Hartford Healthcare Heart and Vascular Institute, Hartford, CT (S.Z.); the Department of Economics, Reimbursement, and Evidence, Medtronic plc, Mounds View, MN (A.L.S., S.A.M.); and Baim Institute for Clinical Research, Boston, MA (M.R.R.).
Abstract
BACKGROUND: In patients with implantable cardioverter-defibrillators, healthcare utilization (HCU) and expenditures related to shocks have not been quantified. METHODS AND RESULTS: We performed a retrospective cohort study of patients with implantable cardioverter-defibrillators identified from commercial and Medicare supplemental claims databases linked to adjudicated shock events from remote monitoring data. A shock event was defined as ≥1 spontaneous shocks delivered by an implanted device. Shock-related HCU was ascertained from inpatient and outpatient claims within 7 days following a shock event. Shock events were adjudicated and classified as inappropriate or appropriate, and HCU and expenditures, stratified by shock type, were quantified. Of 10 266 linked patients, 963 (9.4%) patients (61.3±13.6 years; 81% male) had 1885 shock events (56% appropriate, 38% inappropriate, and 6% indeterminate). Of these events, 867 (46%) had shock-related HCU (14% inpatient and 32% outpatient). After shocks, inpatient cardiovascular procedures were common, including echocardiography (59%), electrophysiology study or ablation (34%), stress testing (16%), and lead revision (11%). Cardiac catheterization was common (71% and 51%), but percutaneous coronary intervention was low (6.5% and 5.0%) after appropriate and inappropriate shocks. Expenditures related to appropriate and inappropriate shocks were not significantly different. CONCLUSIONS: After implantable cardioverter-defibrillator shock, related HCU was common, with 1 in 3 shock events followed by outpatient HCU and 1 in 7 followed by hospitalization. Use of invasive cardiovascular procedures was substantial, even after inappropriate shocks, which comprised 38% of all shocks. Implantable cardioverter-defibrillator shocks seem to trigger a cascade of health care. Strategies to reduce shocks could result in cost savings.
BACKGROUND: In patients with implantable cardioverter-defibrillators, healthcare utilization (HCU) and expenditures related to shocks have not been quantified. METHODS AND RESULTS: We performed a retrospective cohort study of patients with implantable cardioverter-defibrillators identified from commercial and Medicare supplemental claims databases linked to adjudicated shock events from remote monitoring data. A shock event was defined as ≥1 spontaneous shocks delivered by an implanted device. Shock-related HCU was ascertained from inpatient and outpatient claims within 7 days following a shock event. Shock events were adjudicated and classified as inappropriate or appropriate, and HCU and expenditures, stratified by shock type, were quantified. Of 10 266 linked patients, 963 (9.4%) patients (61.3±13.6 years; 81% male) had 1885 shock events (56% appropriate, 38% inappropriate, and 6% indeterminate). Of these events, 867 (46%) had shock-related HCU (14% inpatient and 32% outpatient). After shocks, inpatient cardiovascular procedures were common, including echocardiography (59%), electrophysiology study or ablation (34%), stress testing (16%), and lead revision (11%). Cardiac catheterization was common (71% and 51%), but percutaneous coronary intervention was low (6.5% and 5.0%) after appropriate and inappropriate shocks. Expenditures related to appropriate and inappropriate shocks were not significantly different. CONCLUSIONS: After implantable cardioverter-defibrillator shock, related HCU was common, with 1 in 3 shock events followed by outpatient HCU and 1 in 7 followed by hospitalization. Use of invasive cardiovascular procedures was substantial, even after inappropriate shocks, which comprised 38% of all shocks. Implantable cardioverter-defibrillator shocks seem to trigger a cascade of health care. Strategies to reduce shocks could result in cost savings.
Authors: Susumu Tao; Hiroshi Ashikaga; Luisa A Ciuffo; Kihei Yoneyama; Joao A C Lima; Terry F Frank; Robert G Weiss; Gordon F Tomaselli; Katherine C Wu Journal: J Cardiovasc Electrophysiol Date: 2017-06-22
Authors: Ehud J Schmidt; Hassan Elahi; Eric S Meyer; Ryan Baumgaertner; Luca Neri; Ronald D Berger; Harikrishna Tandri; David W Hunter; Steven P Cohen; Matt T Oberdier; Henry R Halperin Journal: Heart Rhythm Date: 2022-02-28 Impact factor: 6.779
Authors: Daniel Keene; Matthew J Shun-Shin; Ahran D Arnold; James P Howard; David Lefroy; D Wyn Davies; Phang Boon Lim; Fu Siong Ng; Michael Koa-Wing; Norman A Qureshi; Nick W F Linton; Jaymin S Shah; Nicholas S Peters; Prapa Kanagaratnam; Darrel P Francis; Zachary I Whinnett Journal: JACC Clin Electrophysiol Date: 2019-03-27
Authors: Eva R Broers; Paul Lodder; Viola R M Spek; Jos W M G Widdershoven; Susanne S Pedersen; Mirela Habibović Journal: Pacing Clin Electrophysiol Date: 2019-03-05 Impact factor: 1.976
Authors: Bruce L Wilkoff; Laurence D Sterns; Michael S Katcher; Gaurav Upadhyay; Peter Seizer; Chaoyi Kang; Jennifer Rhude; Kevin J Davis; Avi Fischer Journal: Heart Rhythm O2 Date: 2021-11-18
Authors: Christos Zormpas; Kai G Kahl; Stephan Hohmann; Hanno Oswald; Christopher Stiel; Christian Veltmann; Johann Bauersachs; David Duncker Journal: Front Psychiatry Date: 2022-06-17 Impact factor: 5.435